Cite
[Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
MLA
Delektorskaia, V. V., et al. “[Expression of Matrix Metalloproteinases 2 and 9 and Their Tissue Inhibitors 1 and 2 in Papillary Thyroid Cancer: An Association with the Clinical, Morphological and Ultrastructural Characteristics of a Tumor].” Arkhiv Patologii, vol. 72, no. 4, July 2010, pp. 3–6. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21086628&authtype=sso&custid=ns315887.
APA
Delektorskaia, V. V., Smirnova, E. A., Ponomareva, M. V., Pavlova, T. V., & Pavlov, I. A. (2010). [Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor]. Arkhiv Patologii, 72(4), 3–6.
Chicago
Delektorskaia, V V, E A Smirnova, M V Ponomareva, T V Pavlova, and I A Pavlov. 2010. “[Expression of Matrix Metalloproteinases 2 and 9 and Their Tissue Inhibitors 1 and 2 in Papillary Thyroid Cancer: An Association with the Clinical, Morphological and Ultrastructural Characteristics of a Tumor].” Arkhiv Patologii 72 (4): 3–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21086628&authtype=sso&custid=ns315887.